As a dual GLP-1 and GIP receptor agonist, Tirzepatide affects multiple pathways simultaneously: It slows gastric emptying, enhances insulin secretion in a glucose-dependent manner, suppresses glucagon secretion, and powerfully suppresses appetite
GLP Winner Founder and CEO Yesterday the FDA proposed removing GLP-1s from the 503B bulk list, and I spoke to Kurt Lunkwitz from ProRx to talk about changes to GLP-1 compounding
There is no rigorous human evidence defining an optimal cycle length, so these durations are conventional rather than validated
Whether you are beginning your weight loss journey or looking for a more effective alternative to traditional diet programs, our team is committed to helping you achieve lasting results
Animal models of localized IGF-1 overexpression show muscle hypertrophy is satellite cell-dependent (PMID 10632630), and satellite cell activation in humans requires mechanical loading